New York State Common Retirement Fund Decreases Stake in Pulse Biosciences, Inc. (NASDAQ:PLSE)

The New York State Common Retirement Fund (NYSCRF) has recently decreased its stake in Pulse Biosciences, Inc. (NASDAQPLSE). The NYSCRF is a public pension fund that manages the retirement savings of state employees and retirees in New York.

According to a recent filing with the Securities and Exchange Commission (SEC), the NYSCRF sold approximately 1.5 million shares of Pulse Biosciences stock, reducing its stake in the company from about 6.7% to 4.8%. The sale was made for an average price of $20.39 per share, generating net proceeds of approximately $30.6 million.

Pulse Biosciences is a biotechnology company that develops and commercializes products for the treatment of cancer and other diseases. The company's flagship product, Pulsed Light Therapy (PLT), uses light energy to selectively destroy cancer cells without harming healthy tissue.

The NYSCRF's decision to sell its stake in Pulse Biosciences may be due to a variety of factors, including changes in the company's financial performance or strategic direction, as well as the fund's overall investment objectives and risk tolerance. It is important to note that the NYSCRF is a long-term investor and may continue to hold shares in the company if it believes that the stock remains undervalued or has potential for future growth.